TLR4 and alcoholic hepatitis: TAK-242 (Resatorvid), a well-established TLR4-specific drug has currently been used for clinical trials for several inflammatory diseases, for example, severe sepsis (69) and acute alcoholic hepatitis (ClinicalTrials.gov.Identifier: NCT04620148, https://clinicaltrials.gov/ct2/show/NCT04620148).